nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—PTGS2—lung cancer	0.333	1	CbGaD
Nabumetone—MPO—Cisplatin—lung cancer	0.161	0.439	CbGbCtD
Nabumetone—PTGS2—Cisplatin—lung cancer	0.0556	0.152	CbGbCtD
Nabumetone—PTGS2—Etoposide—lung cancer	0.0546	0.149	CbGbCtD
Nabumetone—PTGS1—Etoposide—lung cancer	0.0461	0.126	CbGbCtD
Nabumetone—CYP1A2—Erlotinib—lung cancer	0.0285	0.0777	CbGbCtD
Nabumetone—CYP1A2—Etoposide—lung cancer	0.0206	0.0562	CbGbCtD
Nabumetone—Melatonin—MT3—lung cancer	0.0029	0.562	CrCbGaD
Nabumetone—Naproxen—UGT1A1—lung cancer	0.00119	0.231	CrCbGaD
Nabumetone—Melatonin—CYP1A1—lung cancer	0.00045	0.0874	CrCbGaD
Nabumetone—Naproxen—PTGS2—lung cancer	0.000327	0.0634	CrCbGaD
Nabumetone—Naproxen—ALB—lung cancer	0.000291	0.0565	CrCbGaD
Nabumetone—Thrombocytopenia—Etoposide—lung cancer	0.000139	0.000633	CcSEcCtD
Nabumetone—Liver function test abnormal—Doxorubicin—lung cancer	0.000138	0.00063	CcSEcCtD
Nabumetone—Dyspnoea—Cisplatin—lung cancer	0.000138	0.000629	CcSEcCtD
Nabumetone—Erectile dysfunction—Methotrexate—lung cancer	0.000137	0.000627	CcSEcCtD
Nabumetone—Hyperhidrosis—Etoposide—lung cancer	0.000137	0.000625	CcSEcCtD
Nabumetone—Feeling abnormal—Gemcitabine—lung cancer	0.000137	0.000624	CcSEcCtD
Nabumetone—Shock—Paclitaxel—lung cancer	0.000137	0.000623	CcSEcCtD
Nabumetone—Dizziness—Vinorelbine—lung cancer	0.000137	0.000623	CcSEcCtD
Nabumetone—Photosensitivity reaction—Methotrexate—lung cancer	0.000136	0.000621	CcSEcCtD
Nabumetone—Hypokalaemia—Doxorubicin—lung cancer	0.000136	0.000621	CcSEcCtD
Nabumetone—Thrombocytopenia—Paclitaxel—lung cancer	0.000136	0.00062	CcSEcCtD
Nabumetone—Anorexia—Etoposide—lung cancer	0.000135	0.000616	CcSEcCtD
Nabumetone—Abdominal pain—Irinotecan—lung cancer	0.000135	0.000614	CcSEcCtD
Nabumetone—Body temperature increased—Irinotecan—lung cancer	0.000135	0.000614	CcSEcCtD
Nabumetone—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000135	0.000614	CcSEcCtD
Nabumetone—Decreased appetite—Cisplatin—lung cancer	0.000134	0.000613	CcSEcCtD
Nabumetone—Hyperhidrosis—Paclitaxel—lung cancer	0.000134	0.000613	CcSEcCtD
Nabumetone—Pneumonia—Methotrexate—lung cancer	0.000134	0.00061	CcSEcCtD
Nabumetone—Anaemia—Docetaxel—lung cancer	0.000133	0.000608	CcSEcCtD
Nabumetone—Depression—Methotrexate—lung cancer	0.000133	0.000605	CcSEcCtD
Nabumetone—Anorexia—Paclitaxel—lung cancer	0.000132	0.000604	CcSEcCtD
Nabumetone—Gastritis—Doxorubicin—lung cancer	0.000132	0.000604	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000132	0.000602	CcSEcCtD
Nabumetone—Vomiting—Vinorelbine—lung cancer	0.000131	0.000599	CcSEcCtD
Nabumetone—Body temperature increased—Gemcitabine—lung cancer	0.000131	0.000598	CcSEcCtD
Nabumetone—Renal failure—Methotrexate—lung cancer	0.000131	0.000597	CcSEcCtD
Nabumetone—Rash—Vinorelbine—lung cancer	0.00013	0.000594	CcSEcCtD
Nabumetone—Dermatitis—Vinorelbine—lung cancer	0.00013	0.000593	CcSEcCtD
Nabumetone—Stomatitis—Methotrexate—lung cancer	0.00013	0.000592	CcSEcCtD
Nabumetone—Headache—Vinorelbine—lung cancer	0.000129	0.00059	CcSEcCtD
Nabumetone—Syncope—Docetaxel—lung cancer	0.000129	0.00059	CcSEcCtD
Nabumetone—Asthma—Doxorubicin—lung cancer	0.000129	0.000589	CcSEcCtD
Nabumetone—Dysphagia—Doxorubicin—lung cancer	0.000129	0.000589	CcSEcCtD
Nabumetone—Leukopenia—Docetaxel—lung cancer	0.000129	0.000589	CcSEcCtD
Nabumetone—Palpitations—Docetaxel—lung cancer	0.000127	0.000582	CcSEcCtD
Nabumetone—Feeling abnormal—Cisplatin—lung cancer	0.000127	0.000581	CcSEcCtD
Nabumetone—Paraesthesia—Etoposide—lung cancer	0.000127	0.00058	CcSEcCtD
Nabumetone—Haematuria—Methotrexate—lung cancer	0.000127	0.000579	CcSEcCtD
Nabumetone—Loss of consciousness—Docetaxel—lung cancer	0.000127	0.000578	CcSEcCtD
Nabumetone—Pancreatitis—Doxorubicin—lung cancer	0.000127	0.000578	CcSEcCtD
Nabumetone—Dyspnoea—Etoposide—lung cancer	0.000126	0.000576	CcSEcCtD
Nabumetone—Somnolence—Etoposide—lung cancer	0.000126	0.000575	CcSEcCtD
Nabumetone—Cough—Docetaxel—lung cancer	0.000126	0.000574	CcSEcCtD
Nabumetone—Angina pectoris—Doxorubicin—lung cancer	0.000126	0.000574	CcSEcCtD
Nabumetone—Insomnia—Paclitaxel—lung cancer	0.000126	0.000573	CcSEcCtD
Nabumetone—Hypersensitivity—Irinotecan—lung cancer	0.000125	0.000572	CcSEcCtD
Nabumetone—Paraesthesia—Paclitaxel—lung cancer	0.000125	0.000569	CcSEcCtD
Nabumetone—Hypertension—Docetaxel—lung cancer	0.000124	0.000568	CcSEcCtD
Nabumetone—Agranulocytosis—Methotrexate—lung cancer	0.000124	0.000566	CcSEcCtD
Nabumetone—Dyspnoea—Paclitaxel—lung cancer	0.000124	0.000565	CcSEcCtD
Nabumetone—Somnolence—Paclitaxel—lung cancer	0.000123	0.000563	CcSEcCtD
Nabumetone—Decreased appetite—Etoposide—lung cancer	0.000123	0.000562	CcSEcCtD
Nabumetone—Nausea—Vinorelbine—lung cancer	0.000123	0.00056	CcSEcCtD
Nabumetone—Dyspepsia—Paclitaxel—lung cancer	0.000122	0.000558	CcSEcCtD
Nabumetone—Body temperature increased—Cisplatin—lung cancer	0.000122	0.000558	CcSEcCtD
Nabumetone—Asthenia—Irinotecan—lung cancer	0.000122	0.000557	CcSEcCtD
Nabumetone—Fatigue—Etoposide—lung cancer	0.000122	0.000557	CcSEcCtD
Nabumetone—Constipation—Etoposide—lung cancer	0.000121	0.000553	CcSEcCtD
Nabumetone—Dysuria—Doxorubicin—lung cancer	0.000121	0.000551	CcSEcCtD
Nabumetone—Decreased appetite—Paclitaxel—lung cancer	0.000121	0.000551	CcSEcCtD
Nabumetone—Dry mouth—Docetaxel—lung cancer	0.00012	0.000548	CcSEcCtD
Nabumetone—Haemoglobin—Methotrexate—lung cancer	0.00012	0.000548	CcSEcCtD
Nabumetone—Fatigue—Paclitaxel—lung cancer	0.00012	0.000546	CcSEcCtD
Nabumetone—Haemorrhage—Methotrexate—lung cancer	0.000119	0.000545	CcSEcCtD
Nabumetone—Asthenia—Gemcitabine—lung cancer	0.000119	0.000543	CcSEcCtD
Nabumetone—Constipation—Paclitaxel—lung cancer	0.000119	0.000542	CcSEcCtD
Nabumetone—Confusional state—Docetaxel—lung cancer	0.000119	0.000542	CcSEcCtD
Nabumetone—Photosensitivity reaction—Doxorubicin—lung cancer	0.000118	0.000538	CcSEcCtD
Nabumetone—Anaphylactic shock—Docetaxel—lung cancer	0.000118	0.000537	CcSEcCtD
Nabumetone—Oedema—Docetaxel—lung cancer	0.000118	0.000537	CcSEcCtD
Nabumetone—Weight increased—Doxorubicin—lung cancer	0.000118	0.000536	CcSEcCtD
Nabumetone—Pruritus—Gemcitabine—lung cancer	0.000117	0.000535	CcSEcCtD
Nabumetone—Weight decreased—Doxorubicin—lung cancer	0.000117	0.000533	CcSEcCtD
Nabumetone—Feeling abnormal—Etoposide—lung cancer	0.000117	0.000533	CcSEcCtD
Nabumetone—Hyperglycaemia—Doxorubicin—lung cancer	0.000117	0.000532	CcSEcCtD
Nabumetone—Diarrhoea—Irinotecan—lung cancer	0.000116	0.000532	CcSEcCtD
Nabumetone—Pneumonia—Doxorubicin—lung cancer	0.000116	0.000529	CcSEcCtD
Nabumetone—Gastrointestinal pain—Etoposide—lung cancer	0.000116	0.000528	CcSEcCtD
Nabumetone—Shock—Docetaxel—lung cancer	0.000116	0.000528	CcSEcCtD
Nabumetone—Thrombocytopenia—Docetaxel—lung cancer	0.000115	0.000526	CcSEcCtD
Nabumetone—Visual impairment—Methotrexate—lung cancer	0.000115	0.000525	CcSEcCtD
Nabumetone—Feeling abnormal—Paclitaxel—lung cancer	0.000114	0.000522	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000114	0.000521	CcSEcCtD
Nabumetone—Hypersensitivity—Cisplatin—lung cancer	0.000114	0.00052	CcSEcCtD
Nabumetone—Gastrointestinal pain—Paclitaxel—lung cancer	0.000114	0.000518	CcSEcCtD
Nabumetone—Diarrhoea—Gemcitabine—lung cancer	0.000113	0.000518	CcSEcCtD
Nabumetone—Renal failure—Doxorubicin—lung cancer	0.000113	0.000517	CcSEcCtD
Nabumetone—Erythema multiforme—Methotrexate—lung cancer	0.000113	0.000515	CcSEcCtD
Nabumetone—Dizziness—Irinotecan—lung cancer	0.000113	0.000514	CcSEcCtD
Nabumetone—Urticaria—Etoposide—lung cancer	0.000112	0.000513	CcSEcCtD
Nabumetone—Stomatitis—Doxorubicin—lung cancer	0.000112	0.000512	CcSEcCtD
Nabumetone—Jaundice—Doxorubicin—lung cancer	0.000112	0.000512	CcSEcCtD
Nabumetone—Anorexia—Docetaxel—lung cancer	0.000112	0.000512	CcSEcCtD
Nabumetone—Abdominal pain—Etoposide—lung cancer	0.000112	0.000511	CcSEcCtD
Nabumetone—Body temperature increased—Etoposide—lung cancer	0.000112	0.000511	CcSEcCtD
Nabumetone—Tinnitus—Methotrexate—lung cancer	0.000111	0.000508	CcSEcCtD
Nabumetone—Asthenia—Cisplatin—lung cancer	0.000111	0.000506	CcSEcCtD
Nabumetone—Urticaria—Paclitaxel—lung cancer	0.00011	0.000503	CcSEcCtD
Nabumetone—Haematuria—Doxorubicin—lung cancer	0.00011	0.000501	CcSEcCtD
Nabumetone—Body temperature increased—Paclitaxel—lung cancer	0.00011	0.000501	CcSEcCtD
Nabumetone—Abdominal pain—Paclitaxel—lung cancer	0.00011	0.000501	CcSEcCtD
Nabumetone—Vomiting—Irinotecan—lung cancer	0.000108	0.000494	CcSEcCtD
Nabumetone—Agranulocytosis—Doxorubicin—lung cancer	0.000107	0.00049	CcSEcCtD
Nabumetone—Rash—Irinotecan—lung cancer	0.000107	0.00049	CcSEcCtD
Nabumetone—Dermatitis—Irinotecan—lung cancer	0.000107	0.000489	CcSEcCtD
Nabumetone—Chills—Methotrexate—lung cancer	0.000107	0.000489	CcSEcCtD
Nabumetone—Headache—Irinotecan—lung cancer	0.000107	0.000487	CcSEcCtD
Nabumetone—Insomnia—Docetaxel—lung cancer	0.000106	0.000486	CcSEcCtD
Nabumetone—Diarrhoea—Cisplatin—lung cancer	0.000106	0.000483	CcSEcCtD
Nabumetone—Paraesthesia—Docetaxel—lung cancer	0.000106	0.000482	CcSEcCtD
Nabumetone—Alopecia—Methotrexate—lung cancer	0.000105	0.000481	CcSEcCtD
Nabumetone—Vomiting—Gemcitabine—lung cancer	0.000105	0.000481	CcSEcCtD
Nabumetone—Dyspnoea—Docetaxel—lung cancer	0.000105	0.000479	CcSEcCtD
Nabumetone—Somnolence—Docetaxel—lung cancer	0.000105	0.000477	CcSEcCtD
Nabumetone—Rash—Gemcitabine—lung cancer	0.000105	0.000477	CcSEcCtD
Nabumetone—Dermatitis—Gemcitabine—lung cancer	0.000104	0.000477	CcSEcCtD
Nabumetone—Hypersensitivity—Etoposide—lung cancer	0.000104	0.000476	CcSEcCtD
Nabumetone—Haemoglobin—Doxorubicin—lung cancer	0.000104	0.000474	CcSEcCtD
Nabumetone—Headache—Gemcitabine—lung cancer	0.000104	0.000474	CcSEcCtD
Nabumetone—Dyspepsia—Docetaxel—lung cancer	0.000104	0.000473	CcSEcCtD
Nabumetone—Haemorrhage—Doxorubicin—lung cancer	0.000103	0.000472	CcSEcCtD
Nabumetone—Decreased appetite—Docetaxel—lung cancer	0.000102	0.000467	CcSEcCtD
Nabumetone—Hypersensitivity—Paclitaxel—lung cancer	0.000102	0.000467	CcSEcCtD
Nabumetone—Asthenia—Etoposide—lung cancer	0.000102	0.000464	CcSEcCtD
Nabumetone—Fatigue—Docetaxel—lung cancer	0.000101	0.000463	CcSEcCtD
Nabumetone—Nausea—Irinotecan—lung cancer	0.000101	0.000462	CcSEcCtD
Nabumetone—Constipation—Docetaxel—lung cancer	0.000101	0.000459	CcSEcCtD
Nabumetone—Pruritus—Etoposide—lung cancer	0.0001	0.000457	CcSEcCtD
Nabumetone—Visual impairment—Doxorubicin—lung cancer	9.96e-05	0.000455	CcSEcCtD
Nabumetone—Asthenia—Paclitaxel—lung cancer	9.96e-05	0.000455	CcSEcCtD
Nabumetone—Nausea—Gemcitabine—lung cancer	9.85e-05	0.00045	CcSEcCtD
Nabumetone—Vomiting—Cisplatin—lung cancer	9.83e-05	0.000449	CcSEcCtD
Nabumetone—Pruritus—Paclitaxel—lung cancer	9.82e-05	0.000448	CcSEcCtD
Nabumetone—Erythema multiforme—Doxorubicin—lung cancer	9.77e-05	0.000446	CcSEcCtD
Nabumetone—Rash—Cisplatin—lung cancer	9.75e-05	0.000445	CcSEcCtD
Nabumetone—Dermatitis—Cisplatin—lung cancer	9.74e-05	0.000444	CcSEcCtD
Nabumetone—Feeling abnormal—Docetaxel—lung cancer	9.7e-05	0.000443	CcSEcCtD
Nabumetone—Diarrhoea—Etoposide—lung cancer	9.69e-05	0.000442	CcSEcCtD
Nabumetone—Ill-defined disorder—Methotrexate—lung cancer	9.64e-05	0.00044	CcSEcCtD
Nabumetone—Tinnitus—Doxorubicin—lung cancer	9.64e-05	0.00044	CcSEcCtD
Nabumetone—Gastrointestinal pain—Docetaxel—lung cancer	9.62e-05	0.000439	CcSEcCtD
Nabumetone—Anaemia—Methotrexate—lung cancer	9.61e-05	0.000438	CcSEcCtD
Nabumetone—Diarrhoea—Paclitaxel—lung cancer	9.5e-05	0.000434	CcSEcCtD
Nabumetone—Malaise—Methotrexate—lung cancer	9.37e-05	0.000428	CcSEcCtD
Nabumetone—Dizziness—Etoposide—lung cancer	9.36e-05	0.000427	CcSEcCtD
Nabumetone—Vertigo—Methotrexate—lung cancer	9.34e-05	0.000426	CcSEcCtD
Nabumetone—Abdominal pain—Docetaxel—lung cancer	9.3e-05	0.000425	CcSEcCtD
Nabumetone—Body temperature increased—Docetaxel—lung cancer	9.3e-05	0.000425	CcSEcCtD
Nabumetone—Leukopenia—Methotrexate—lung cancer	9.3e-05	0.000425	CcSEcCtD
Nabumetone—Chills—Doxorubicin—lung cancer	9.28e-05	0.000423	CcSEcCtD
Nabumetone—Arrhythmia—Doxorubicin—lung cancer	9.24e-05	0.000421	CcSEcCtD
Nabumetone—Dizziness—Paclitaxel—lung cancer	9.18e-05	0.000419	CcSEcCtD
Nabumetone—Nausea—Cisplatin—lung cancer	9.18e-05	0.000419	CcSEcCtD
Nabumetone—Alopecia—Doxorubicin—lung cancer	9.14e-05	0.000417	CcSEcCtD
Nabumetone—Cough—Methotrexate—lung cancer	9.07e-05	0.000414	CcSEcCtD
Nabumetone—Vomiting—Etoposide—lung cancer	9e-05	0.000411	CcSEcCtD
Nabumetone—Rash—Etoposide—lung cancer	8.93e-05	0.000407	CcSEcCtD
Nabumetone—Dermatitis—Etoposide—lung cancer	8.92e-05	0.000407	CcSEcCtD
Nabumetone—Headache—Etoposide—lung cancer	8.87e-05	0.000405	CcSEcCtD
Nabumetone—Flatulence—Doxorubicin—lung cancer	8.87e-05	0.000405	CcSEcCtD
Nabumetone—Tension—Doxorubicin—lung cancer	8.83e-05	0.000403	CcSEcCtD
Nabumetone—Vomiting—Paclitaxel—lung cancer	8.83e-05	0.000403	CcSEcCtD
Nabumetone—Rash—Paclitaxel—lung cancer	8.75e-05	0.0004	CcSEcCtD
Nabumetone—Dermatitis—Paclitaxel—lung cancer	8.75e-05	0.000399	CcSEcCtD
Nabumetone—Discomfort—Methotrexate—lung cancer	8.74e-05	0.000399	CcSEcCtD
Nabumetone—Nervousness—Doxorubicin—lung cancer	8.74e-05	0.000399	CcSEcCtD
Nabumetone—Headache—Paclitaxel—lung cancer	8.7e-05	0.000397	CcSEcCtD
Nabumetone—Hypersensitivity—Docetaxel—lung cancer	8.67e-05	0.000396	CcSEcCtD
Nabumetone—Confusional state—Methotrexate—lung cancer	8.55e-05	0.00039	CcSEcCtD
Nabumetone—Anaphylactic shock—Methotrexate—lung cancer	8.48e-05	0.000387	CcSEcCtD
Nabumetone—Asthenia—Docetaxel—lung cancer	8.44e-05	0.000385	CcSEcCtD
Nabumetone—Nausea—Etoposide—lung cancer	8.41e-05	0.000384	CcSEcCtD
Nabumetone—Ill-defined disorder—Doxorubicin—lung cancer	8.35e-05	0.000381	CcSEcCtD
Nabumetone—Pruritus—Docetaxel—lung cancer	8.33e-05	0.00038	CcSEcCtD
Nabumetone—Anaemia—Doxorubicin—lung cancer	8.32e-05	0.00038	CcSEcCtD
Nabumetone—Thrombocytopenia—Methotrexate—lung cancer	8.3e-05	0.000379	CcSEcCtD
Nabumetone—Agitation—Doxorubicin—lung cancer	8.27e-05	0.000377	CcSEcCtD
Nabumetone—Nausea—Paclitaxel—lung cancer	8.25e-05	0.000376	CcSEcCtD
Nabumetone—Hyperhidrosis—Methotrexate—lung cancer	8.2e-05	0.000374	CcSEcCtD
Nabumetone—Malaise—Doxorubicin—lung cancer	8.12e-05	0.00037	CcSEcCtD
Nabumetone—Vertigo—Doxorubicin—lung cancer	8.09e-05	0.000369	CcSEcCtD
Nabumetone—Anorexia—Methotrexate—lung cancer	8.09e-05	0.000369	CcSEcCtD
Nabumetone—Syncope—Doxorubicin—lung cancer	8.07e-05	0.000368	CcSEcCtD
Nabumetone—Leukopenia—Doxorubicin—lung cancer	8.06e-05	0.000368	CcSEcCtD
Nabumetone—Diarrhoea—Docetaxel—lung cancer	8.05e-05	0.000367	CcSEcCtD
Nabumetone—Palpitations—Doxorubicin—lung cancer	7.95e-05	0.000363	CcSEcCtD
Nabumetone—Loss of consciousness—Doxorubicin—lung cancer	7.91e-05	0.000361	CcSEcCtD
Nabumetone—Cough—Doxorubicin—lung cancer	7.85e-05	0.000358	CcSEcCtD
Nabumetone—Dizziness—Docetaxel—lung cancer	7.78e-05	0.000355	CcSEcCtD
Nabumetone—Hypertension—Doxorubicin—lung cancer	7.77e-05	0.000355	CcSEcCtD
Nabumetone—Insomnia—Methotrexate—lung cancer	7.67e-05	0.00035	CcSEcCtD
Nabumetone—Anxiety—Doxorubicin—lung cancer	7.64e-05	0.000348	CcSEcCtD
Nabumetone—Paraesthesia—Methotrexate—lung cancer	7.62e-05	0.000348	CcSEcCtD
Nabumetone—Discomfort—Doxorubicin—lung cancer	7.57e-05	0.000345	CcSEcCtD
Nabumetone—Dyspnoea—Methotrexate—lung cancer	7.56e-05	0.000345	CcSEcCtD
Nabumetone—Somnolence—Methotrexate—lung cancer	7.54e-05	0.000344	CcSEcCtD
Nabumetone—Dry mouth—Doxorubicin—lung cancer	7.49e-05	0.000342	CcSEcCtD
Nabumetone—Vomiting—Docetaxel—lung cancer	7.48e-05	0.000341	CcSEcCtD
Nabumetone—Dyspepsia—Methotrexate—lung cancer	7.47e-05	0.000341	CcSEcCtD
Nabumetone—Rash—Docetaxel—lung cancer	7.42e-05	0.000339	CcSEcCtD
Nabumetone—Dermatitis—Docetaxel—lung cancer	7.41e-05	0.000338	CcSEcCtD
Nabumetone—Confusional state—Doxorubicin—lung cancer	7.41e-05	0.000338	CcSEcCtD
Nabumetone—Decreased appetite—Methotrexate—lung cancer	7.37e-05	0.000337	CcSEcCtD
Nabumetone—Headache—Docetaxel—lung cancer	7.37e-05	0.000336	CcSEcCtD
Nabumetone—Oedema—Doxorubicin—lung cancer	7.34e-05	0.000335	CcSEcCtD
Nabumetone—Anaphylactic shock—Doxorubicin—lung cancer	7.34e-05	0.000335	CcSEcCtD
Nabumetone—Fatigue—Methotrexate—lung cancer	7.31e-05	0.000334	CcSEcCtD
Nabumetone—Shock—Doxorubicin—lung cancer	7.23e-05	0.00033	CcSEcCtD
Nabumetone—Thrombocytopenia—Doxorubicin—lung cancer	7.19e-05	0.000328	CcSEcCtD
Nabumetone—Hyperhidrosis—Doxorubicin—lung cancer	7.1e-05	0.000324	CcSEcCtD
Nabumetone—Anorexia—Doxorubicin—lung cancer	7e-05	0.00032	CcSEcCtD
Nabumetone—Nausea—Docetaxel—lung cancer	6.99e-05	0.000319	CcSEcCtD
Nabumetone—Feeling abnormal—Methotrexate—lung cancer	6.99e-05	0.000319	CcSEcCtD
Nabumetone—Gastrointestinal pain—Methotrexate—lung cancer	6.94e-05	0.000317	CcSEcCtD
Nabumetone—Urticaria—Methotrexate—lung cancer	6.74e-05	0.000308	CcSEcCtD
Nabumetone—Abdominal pain—Methotrexate—lung cancer	6.71e-05	0.000306	CcSEcCtD
Nabumetone—Body temperature increased—Methotrexate—lung cancer	6.71e-05	0.000306	CcSEcCtD
Nabumetone—Insomnia—Doxorubicin—lung cancer	6.64e-05	0.000303	CcSEcCtD
Nabumetone—Paraesthesia—Doxorubicin—lung cancer	6.59e-05	0.000301	CcSEcCtD
Nabumetone—Dyspnoea—Doxorubicin—lung cancer	6.55e-05	0.000299	CcSEcCtD
Nabumetone—Somnolence—Doxorubicin—lung cancer	6.53e-05	0.000298	CcSEcCtD
Nabumetone—Dyspepsia—Doxorubicin—lung cancer	6.47e-05	0.000295	CcSEcCtD
Nabumetone—Decreased appetite—Doxorubicin—lung cancer	6.38e-05	0.000291	CcSEcCtD
Nabumetone—Fatigue—Doxorubicin—lung cancer	6.33e-05	0.000289	CcSEcCtD
Nabumetone—Constipation—Doxorubicin—lung cancer	6.28e-05	0.000287	CcSEcCtD
Nabumetone—Hypersensitivity—Methotrexate—lung cancer	6.25e-05	0.000285	CcSEcCtD
Nabumetone—Asthenia—Methotrexate—lung cancer	6.09e-05	0.000278	CcSEcCtD
Nabumetone—Feeling abnormal—Doxorubicin—lung cancer	6.05e-05	0.000276	CcSEcCtD
Nabumetone—Gastrointestinal pain—Doxorubicin—lung cancer	6.01e-05	0.000274	CcSEcCtD
Nabumetone—Pruritus—Methotrexate—lung cancer	6e-05	0.000274	CcSEcCtD
Nabumetone—Urticaria—Doxorubicin—lung cancer	5.83e-05	0.000266	CcSEcCtD
Nabumetone—Abdominal pain—Doxorubicin—lung cancer	5.81e-05	0.000265	CcSEcCtD
Nabumetone—Body temperature increased—Doxorubicin—lung cancer	5.81e-05	0.000265	CcSEcCtD
Nabumetone—Diarrhoea—Methotrexate—lung cancer	5.8e-05	0.000265	CcSEcCtD
Nabumetone—Dizziness—Methotrexate—lung cancer	5.61e-05	0.000256	CcSEcCtD
Nabumetone—Hypersensitivity—Doxorubicin—lung cancer	5.41e-05	0.000247	CcSEcCtD
Nabumetone—Vomiting—Methotrexate—lung cancer	5.39e-05	0.000246	CcSEcCtD
Nabumetone—Rash—Methotrexate—lung cancer	5.35e-05	0.000244	CcSEcCtD
Nabumetone—Dermatitis—Methotrexate—lung cancer	5.34e-05	0.000244	CcSEcCtD
Nabumetone—Headache—Methotrexate—lung cancer	5.31e-05	0.000243	CcSEcCtD
Nabumetone—Asthenia—Doxorubicin—lung cancer	5.27e-05	0.00024	CcSEcCtD
Nabumetone—Pruritus—Doxorubicin—lung cancer	5.2e-05	0.000237	CcSEcCtD
Nabumetone—Nausea—Methotrexate—lung cancer	5.04e-05	0.00023	CcSEcCtD
Nabumetone—Diarrhoea—Doxorubicin—lung cancer	5.03e-05	0.000229	CcSEcCtD
Nabumetone—Dizziness—Doxorubicin—lung cancer	4.86e-05	0.000222	CcSEcCtD
Nabumetone—Vomiting—Doxorubicin—lung cancer	4.67e-05	0.000213	CcSEcCtD
Nabumetone—Rash—Doxorubicin—lung cancer	4.63e-05	0.000211	CcSEcCtD
Nabumetone—Dermatitis—Doxorubicin—lung cancer	4.63e-05	0.000211	CcSEcCtD
Nabumetone—Headache—Doxorubicin—lung cancer	4.6e-05	0.00021	CcSEcCtD
Nabumetone—Nausea—Doxorubicin—lung cancer	4.36e-05	0.000199	CcSEcCtD
Nabumetone—PTGS2—Metabolism—MTMR3—lung cancer	3.83e-05	0.000501	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—B4GALT5—lung cancer	3.76e-05	0.000491	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	3.75e-05	0.00049	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PGAM1—lung cancer	3.73e-05	0.000488	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—COL4A3BP—lung cancer	3.68e-05	0.000481	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—AZIN2—lung cancer	3.68e-05	0.000481	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SKI—lung cancer	3.67e-05	0.00048	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GSTA4—lung cancer	3.65e-05	0.000478	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	3.65e-05	0.000477	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	3.64e-05	0.000476	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	3.57e-05	0.000467	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GSTA2—lung cancer	3.56e-05	0.000466	CbGpPWpGaD
Nabumetone—PTGS2—Disease—B4GALT5—lung cancer	3.56e-05	0.000466	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP2A7—lung cancer	3.56e-05	0.000465	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—TP53—lung cancer	3.53e-05	0.000462	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	3.53e-05	0.000462	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	3.52e-05	0.000461	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SDC4—lung cancer	3.48e-05	0.000456	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GSTA1—lung cancer	3.44e-05	0.000449	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	3.43e-05	0.000448	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ABCC3—lung cancer	3.4e-05	0.000444	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	3.36e-05	0.000439	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	3.32e-05	0.000434	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—AKR1C1—lung cancer	3.29e-05	0.00043	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	3.27e-05	0.000427	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL6—lung cancer	3.23e-05	0.000423	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—UGT1A1—lung cancer	3.19e-05	0.000418	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PXN—lung cancer	3.19e-05	0.000417	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	3.18e-05	0.000416	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—RRM1—lung cancer	3.17e-05	0.000415	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTA3—lung cancer	3.17e-05	0.000415	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ATP5H—lung cancer	3.13e-05	0.000409	CbGpPWpGaD
Nabumetone—PTGS2—Disease—AKR1C1—lung cancer	3.12e-05	0.000408	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—POMC—lung cancer	3.12e-05	0.000407	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GNG11—lung cancer	3.08e-05	0.000403	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—APOA1—lung cancer	3.06e-05	0.000401	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	3.01e-05	0.000394	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—B4GALT5—lung cancer	2.98e-05	0.00039	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ALDOA—lung cancer	2.93e-05	0.000384	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	2.93e-05	0.000383	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTA4—lung cancer	2.9e-05	0.000379	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	2.87e-05	0.000376	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NPPA—lung cancer	2.87e-05	0.000375	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	2.86e-05	0.000374	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NCOA3—lung cancer	2.85e-05	0.000372	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.84e-05	0.000371	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTA2—lung cancer	2.83e-05	0.00037	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PPIA—lung cancer	2.8e-05	0.000366	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.8e-05	0.000366	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PLBD1—lung cancer	2.79e-05	0.000364	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ALDOA—lung cancer	2.78e-05	0.000364	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ADCY1—lung cancer	2.77e-05	0.000362	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ABCG2—lung cancer	2.77e-05	0.000362	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	2.74e-05	0.000358	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTA1—lung cancer	2.73e-05	0.000357	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ENO2—lung cancer	2.72e-05	0.000355	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—HPGDS—lung cancer	2.72e-05	0.000355	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	2.7e-05	0.000354	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PPP2R1B—lung cancer	2.7e-05	0.000353	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ABCC3—lung cancer	2.7e-05	0.000353	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.66e-05	0.000348	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GSTT1—lung cancer	2.63e-05	0.000345	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ADCY1—lung cancer	2.63e-05	0.000343	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—AKR1C1—lung cancer	2.61e-05	0.000342	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP2A6—lung cancer	2.6e-05	0.000341	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GCLC—lung cancer	2.6e-05	0.000341	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.59e-05	0.000339	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ENO2—lung cancer	2.57e-05	0.000337	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PPP2R1B—lung cancer	2.56e-05	0.000335	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SMARCA4—lung cancer	2.56e-05	0.000335	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HSD17B10—lung cancer	2.55e-05	0.000333	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—UGT1A1—lung cancer	2.54e-05	0.000332	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	2.48e-05	0.000325	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ENO1—lung cancer	2.47e-05	0.000323	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.46e-05	0.000322	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GNG11—lung cancer	2.45e-05	0.00032	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.43e-05	0.000318	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.43e-05	0.000318	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	2.4e-05	0.000314	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CKB—lung cancer	2.37e-05	0.00031	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ENO1—lung cancer	2.34e-05	0.000306	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ALDOA—lung cancer	2.33e-05	0.000305	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NCOA3—lung cancer	2.26e-05	0.000296	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTM2—lung cancer	2.23e-05	0.000291	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CNDP2—lung cancer	2.23e-05	0.000291	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.22e-05	0.00029	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP2E1—lung cancer	2.21e-05	0.00029	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ADCY1—lung cancer	2.2e-05	0.000288	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ABCG2—lung cancer	2.2e-05	0.000288	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NQO1—lung cancer	2.19e-05	0.000286	CbGpPWpGaD
Nabumetone—PTGS2—Disease—APP—lung cancer	2.18e-05	0.000285	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—MTMR3—lung cancer	2.17e-05	0.000283	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FGF9—lung cancer	2.16e-05	0.000282	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ENO2—lung cancer	2.16e-05	0.000282	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HPGDS—lung cancer	2.16e-05	0.000282	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.14e-05	0.00028	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PPP2R1B—lung cancer	2.14e-05	0.00028	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.12e-05	0.000278	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.11e-05	0.000277	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PGAM1—lung cancer	2.11e-05	0.000276	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTT1—lung cancer	2.09e-05	0.000274	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GCLC—lung cancer	2.07e-05	0.00027	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP2A6—lung cancer	2.07e-05	0.00027	CbGpPWpGaD
Nabumetone—PTGS2—Disease—JUNB—lung cancer	2.06e-05	0.000269	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.06e-05	0.000269	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	2.03e-05	0.000265	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP2A7—lung cancer	2.01e-05	0.000263	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—STK11—lung cancer	1.97e-05	0.000258	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SDC4—lung cancer	1.97e-05	0.000258	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ENO1—lung cancer	1.96e-05	0.000256	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.95e-05	0.000255	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.93e-05	0.000252	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.85e-05	0.000242	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GSTP1—lung cancer	1.83e-05	0.000239	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FOXO3—lung cancer	1.81e-05	0.000236	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—RRM1—lung cancer	1.8e-05	0.000235	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTA3—lung cancer	1.8e-05	0.000235	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CAT—lung cancer	1.78e-05	0.000232	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.77e-05	0.000231	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP2E1—lung cancer	1.76e-05	0.00023	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NQO1—lung cancer	1.74e-05	0.000227	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ABCB1—lung cancer	1.73e-05	0.000226	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.7e-05	0.000223	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—TYMS—lung cancer	1.7e-05	0.000222	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—B4GALT5—lung cancer	1.69e-05	0.000221	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GSTM1—lung cancer	1.68e-05	0.000219	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTA4—lung cancer	1.64e-05	0.000215	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.6e-05	0.00021	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTA2—lung cancer	1.6e-05	0.000209	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HES1—lung cancer	1.6e-05	0.000209	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP1A1—lung cancer	1.59e-05	0.000208	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ERCC2—lung cancer	1.58e-05	0.000206	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—STK11—lung cancer	1.57e-05	0.000205	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTA1—lung cancer	1.54e-05	0.000202	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ABCC3—lung cancer	1.53e-05	0.0002	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ERCC2—lung cancer	1.5e-05	0.000196	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—AKR1C1—lung cancer	1.48e-05	0.000193	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.47e-05	0.000192	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ERBB3—lung cancer	1.46e-05	0.000191	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTP1—lung cancer	1.45e-05	0.00019	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—UGT1A1—lung cancer	1.44e-05	0.000188	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CAT—lung cancer	1.41e-05	0.000184	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.4e-05	0.000183	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TERT—lung cancer	1.4e-05	0.000183	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GNG11—lung cancer	1.38e-05	0.000181	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.38e-05	0.00018	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ABCB1—lung cancer	1.37e-05	0.000179	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—APOA1—lung cancer	1.36e-05	0.000179	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FGFR1—lung cancer	1.36e-05	0.000178	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—TYMS—lung cancer	1.35e-05	0.000176	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HIF1A—lung cancer	1.34e-05	0.000175	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTM1—lung cancer	1.33e-05	0.000174	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALDOA—lung cancer	1.32e-05	0.000172	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.31e-05	0.000171	CbGpPWpGaD
Nabumetone—PTGS2—Disease—APOA1—lung cancer	1.29e-05	0.000169	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NCOA3—lung cancer	1.28e-05	0.000167	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP1A1—lung cancer	1.26e-05	0.000165	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.26e-05	0.000164	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ERCC2—lung cancer	1.25e-05	0.000164	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PIK3CG—lung cancer	1.25e-05	0.000163	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ABCG2—lung cancer	1.24e-05	0.000163	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ADCY1—lung cancer	1.24e-05	0.000163	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ENO2—lung cancer	1.22e-05	0.00016	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HPGDS—lung cancer	1.22e-05	0.00016	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PPP2R1B—lung cancer	1.21e-05	0.000159	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.2e-05	0.000156	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—POMC—lung cancer	1.19e-05	0.000155	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTT1—lung cancer	1.18e-05	0.000155	CbGpPWpGaD
Nabumetone—PTGS2—Disease—APC—lung cancer	1.18e-05	0.000154	CbGpPWpGaD
Nabumetone—PTGS2—Disease—KIT—lung cancer	1.18e-05	0.000154	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GCLC—lung cancer	1.17e-05	0.000153	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP2A6—lung cancer	1.17e-05	0.000153	CbGpPWpGaD
Nabumetone—PTGS2—Disease—EGF—lung cancer	1.17e-05	0.000153	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.17e-05	0.000152	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CREBBP—lung cancer	1.16e-05	0.000151	CbGpPWpGaD
Nabumetone—PTGS2—Disease—BRAF—lung cancer	1.11e-05	0.000145	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ENO1—lung cancer	1.11e-05	0.000145	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.11e-05	0.000145	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IL6R—lung cancer	1.1e-05	0.000143	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PIK3CD—lung cancer	1.1e-05	0.000143	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CREBBP—lung cancer	1.1e-05	0.000143	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.09e-05	0.000143	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—APOA1—lung cancer	1.08e-05	0.000142	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ALB—lung cancer	1.08e-05	0.000141	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MAP2K1—lung cancer	1.05e-05	0.000137	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PIK3CD—lung cancer	1.04e-05	0.000136	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.04e-05	0.000136	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP2E1—lung cancer	9.95e-06	0.00013	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PIK3CG—lung cancer	9.89e-06	0.000129	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NQO1—lung cancer	9.84e-06	0.000129	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.63e-06	0.000126	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PIK3CB—lung cancer	9.55e-06	0.000125	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	9.54e-06	0.000125	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PTGS2—lung cancer	9.46e-06	0.000124	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—POMC—lung cancer	9.42e-06	0.000123	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MDM2—lung cancer	9.3e-06	0.000122	CbGpPWpGaD
Nabumetone—PTGS2—Disease—RAF1—lung cancer	9.27e-06	0.000121	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CREBBP—lung cancer	9.17e-06	0.00012	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ERBB2—lung cancer	9.17e-06	0.00012	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MTOR—lung cancer	9.05e-06	0.000118	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PIK3CB—lung cancer	9.05e-06	0.000118	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CD4—lung cancer	9.03e-06	0.000118	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—STK11—lung cancer	8.87e-06	0.000116	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PIK3CD—lung cancer	8.7e-06	0.000114	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ALB—lung cancer	8.58e-06	0.000112	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.32e-06	0.000109	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PTEN—lung cancer	8.25e-06	0.000108	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTP1—lung cancer	8.2e-06	0.000107	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CAT—lung cancer	7.98e-06	0.000104	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.94e-06	0.000104	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—EP300—lung cancer	7.87e-06	0.000103	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CDKN1A—lung cancer	7.84e-06	0.000103	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PTEN—lung cancer	7.82e-06	0.000102	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ABCB1—lung cancer	7.77e-06	0.000102	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—TYMS—lung cancer	7.63e-06	9.97e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PIK3CB—lung cancer	7.58e-06	9.91e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTM1—lung cancer	7.54e-06	9.86e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—EP300—lung cancer	7.46e-06	9.75e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SRC—lung cancer	7.25e-06	9.49e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP1A1—lung cancer	7.15e-06	9.35e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ERCC2—lung cancer	7.09e-06	9.27e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—STAT3—lung cancer	6.99e-06	9.15e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NRAS—lung cancer	6.98e-06	9.13e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MAPK3—lung cancer	6.68e-06	8.74e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PTEN—lung cancer	6.55e-06	8.57e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MYC—lung cancer	6.5e-06	8.5e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—EGFR—lung cancer	6.36e-06	8.31e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—EP300—lung cancer	6.25e-06	8.17e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—APOA1—lung cancer	6.13e-06	8.02e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—KRAS—lung cancer	6.01e-06	7.85e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.87e-06	7.68e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PIK3CA—lung cancer	5.82e-06	7.61e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PIK3CG—lung cancer	5.6e-06	7.32e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PIK3CA—lung cancer	5.52e-06	7.22e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—POMC—lung cancer	5.33e-06	6.97e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CREBBP—lung cancer	5.19e-06	6.79e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HRAS—lung cancer	5.1e-06	6.68e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PIK3CD—lung cancer	4.92e-06	6.44e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IL6—lung cancer	4.89e-06	6.39e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALB—lung cancer	4.86e-06	6.35e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—AKT1—lung cancer	4.76e-06	6.22e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PIK3CA—lung cancer	4.62e-06	6.04e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—AKT1—lung cancer	4.51e-06	5.89e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PIK3CB—lung cancer	4.29e-06	5.61e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PTGS2—lung cancer	4.25e-06	5.56e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—AKT1—lung cancer	3.77e-06	4.94e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PTEN—lung cancer	3.71e-06	4.85e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—EP300—lung cancer	3.53e-06	4.62e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PIK3CA—lung cancer	2.61e-06	3.42e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—AKT1—lung cancer	2.14e-06	2.79e-05	CbGpPWpGaD
